Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 25:13:1197850.
doi: 10.3389/fonc.2023.1197850. eCollection 2023.

Incidence and time trends of childhood hematological neoplasms: a 36-year population-based study in the southern European context, 1983-2018

Affiliations

Incidence and time trends of childhood hematological neoplasms: a 36-year population-based study in the southern European context, 1983-2018

Jan Trallero et al. Front Oncol. .

Abstract

Background: Hematological neoplasms (HNs) are the first and most common childhood cancers globally. Currently, there is a lack of updated population-based data on the incidence of these cancers in the Spanish pediatric population. This study aimed to describe the incidence and incidence trends of HNs in children (0-14 years) in Spain using data from the Spanish Network of Cancer Registries and to compare the results with other southern European countries.

Methods: Data were extracted from 15 Spanish population-based cancer registries between 1983 and 2018. Cases were coded according to the International Classification of Diseases for Oncology, third edition, first revision, and grouped according to the International Classification of Childhood Cancer, third edition. Crude rates (CRs), age-specific rates, and age-standardized incidence rates using the 2013 European population (ASRE) were calculated and expressed as cases per 1,000,000 child-years. Incidence trends and annual percentage changes (APCs) were estimated.

Results: A total of 4,747 HNs were recorded (59.5% boys). Age distribution [n (%)] was as follows: <1 year, 266 (5.6%); 1-4 years, 1,726 (36.4%); 5-9 years, 1,442 (30.4%); and 10-14 years, 1,313 (27.6%). Leukemias were the most common group, with a CR and an ASRE of 44.0 (95%CI: 42.5; 45.5) and 44.1 (95%CI: 42.6; 45.7), respectively. The CR and ASRE of lymphomas were 20.1 (95%CI: 19.1; 21.1) and 20.0 (95%CI: 19.0; 21.1), respectively. The comparable incidence rates between our results and those of other southern European countries were similar for lymphomas, while some differences were observed for leukemias. From 1988 to 2016, the trend in leukemia incidence was stable for both sexes, with an APC of 0.0 (95%CI: -0.5; 0.7), whereas a constant overall increase was observed for lymphoma in both sexes, with an APC of 1.0 (95%CI: 0.4; 1.6).

Conclusion: Leukemias are the most common HNs in children, and their incidence has remained stable since 1988, whereas the incidence of lymphomas has increased every year. Lymphoma incidence is like that of other southern European countries, while leukemia incidence is similar only to that of southwestern European countries. Collaborative cancer registry projects allow for assessing epidemiological indicators for cancers such as HNs, which helps health authorities and clinicians provide more knowledge about these malignancies.

Keywords: childhood; hematological neoplasms; incidence; incidence trends; leukemia-lymphoma; population-based registries.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Number of cases and percentage. (A) Leukemias and lymphomas. (B) Leukemias and lymphomas by sex. (C) Leukemias and lymphomas by age group.
Figure 2
Figure 2
Trends of age-standardized rates using the 2013 European standard population during the period 1985-2016 in Spain. (A) All hematological neoplasms. (B) Leukemias. (C) Lymphomas.

References

    1. Steliarova-Foucher E, Colombet M, Ries LAG, Hesseling P, Moreno F, Shin HY, et al. . International Incidence of Childhood Cancer Vol. III. . Lyon, France: International Agency for Research on Cancer; (2017).
    1. Davis AS, Viera AJ, Mead MD. Leukemia: an overview for primary care. Am Fam Physician (2014) 89:731–8. - PubMed
    1. Schmidt JA, Hornhardt S, Erdmann F, Sánchez-García I, Fischer U, Schüz J, et al. . Risk factors for childhood leukemia: radiation and beyond. Front Public Heal (2021) 9:805757. doi: 10.3389/FPUBH.2021.805757 - DOI - PMC - PubMed
    1. Matasar MJ, Zelenetz AD. Overview of lymphoma diagnosis and management. Radiol Clin North Am (2008) 46:175–98. doi: 10.1016/J.RCL.2008.03.005 - DOI - PubMed
    1. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International Classification of Childhood Cancer, third edition. Cancer (2005) 103:1457–67. doi: 10.1002/cncr.20910 - DOI - PubMed

LinkOut - more resources